Your browser doesn't support javascript.
loading
Resolving the immune landscape of human prostate at a single-cell level in health and cancer.
Tuong, Zewen Kelvin; Loudon, Kevin W; Berry, Brendan; Richoz, Nathan; Jones, Julia; Tan, Xiao; Nguyen, Quan; George, Anne; Hori, Satoshi; Field, Sarah; Lynch, Andy G; Kania, Katarzyna; Coupland, Paul; Babbage, Anne; Grenfell, Richard; Barrett, Tristan; Warren, Anne Y; Gnanapragasam, Vincent; Massie, Charlie; Clatworthy, Menna R.
Afiliação
  • Tuong ZK; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK.
  • Loudon KW; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Berry B; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Richoz N; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Jones J; CRUK Cambridge Institute, Cambridge, UK.
  • Tan X; Division of Genetics and Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia.
  • Nguyen Q; Division of Genetics and Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia.
  • George A; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Early Detection Programme, CRUK Cambridge Centre, Cambridge, UK.
  • Hori S; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.
  • Field S; CRUK Cambridge Institute, Cambridge, UK.
  • Lynch AG; CRUK Cambridge Institute, Cambridge, UK; School of Mathematics and Statistics/School of Medicine, University of St Andrews, St Andrews, UK.
  • Kania K; CRUK Cambridge Institute, Cambridge, UK.
  • Coupland P; CRUK Cambridge Institute, Cambridge, UK.
  • Babbage A; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Grenfell R; CRUK Cambridge Institute, Cambridge, UK.
  • Barrett T; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Warren AY; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Gnanapragasam V; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK; Cambridge Urology Translational Research and Clinical Trials, Cambridge Biomedical Campus, Cambridge, UK.
  • Massie C; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; CRUK Cambridge Institute, Cambridge, UK; Early Detection Programme, CRUK Cambridge Centre, Cambridge, UK. Electronic address: cem45@hutchison-mrc.cam.ac.uk.
  • Clatworthy MR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Institute of Therapeutic Immunology & Infectious Diseases, Cambridge, UK. Electr
Cell Rep ; 37(12): 110132, 2021 12 21.
Article em En | MEDLINE | ID: mdl-34936871
ABSTRACT
The prostate gland produces prostatic fluid, high in zinc and citrate and essential for the maintenance of spermatozoa. Prostate cancer is a common condition with limited treatment efficacy in castration-resistant metastatic disease, including with immune checkpoint inhibitors. Using single-cell RNA-sequencing to perform an unbiased assessment of the cellular landscape of human prostate, we identify a subset of tumor-enriched androgen receptor-negative luminal epithelial cells with increased expression of cancer-associated genes. We also find a variety of innate and adaptive immune cells in normal prostate that were transcriptionally perturbed in prostate cancer. An exception is a prostate-specific, zinc transporter-expressing macrophage population (MAC-MT) that contributes to tissue zinc accumulation in homeostasis but shows enhanced inflammatory gene expression in tumors, including T cell-recruiting chemokines. Remarkably, enrichment of the MAC-MT signature in cancer biopsies is associated with improved disease-free survival, suggesting beneficial antitumor functions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Células Epiteliais / Transcriptoma / Macrófagos Limite: Aged / Animals / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata / Células Epiteliais / Transcriptoma / Macrófagos Limite: Aged / Animals / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido